Biote Q4 revenue $46.4M; net income $2.6M; anticipates procedure growth H2 2026

biote Corp.

Q4 2025 revenue $46.4M, gross margin 68.0%; net income $2.6M ($0.06 diluted EPS), down from $3.5M ($0.10) in Q4 2024.
Full year 2025 revenue $192.2M; net income $31.6M ($0.74 diluted EPS), versus $0.05M ($0.09) in 2024.
Adjusted EBITDA Q4 $11.7M (25.2% margin); full year adjusted EBITDA $53.5M (27.8% margin).
CEO Bret Christensen anticipates return to procedure revenue growth in second half of 2026.
Company rebuilding commercial sales coverage; commercial transition impacted 2025 results as expected.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.